Maxwell Tawanda Chirehwa
Maxwell Tawanda Chirehwa
Research Officer, Division of Clinical Pharmacology, University Of Cape Town
Verified email at
Cited by
Cited by
Consequences of polyparasitism on anaemia among primary school children in Zimbabwe
N Midzi, S Mtapuri-Zinyowera, MP Mapingure, D Sangweme, ...
Acta tropica 115 (1-2), 103-111, 2010
Impact of Xpert MTB/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled Trial.
MR Mupfumi L, Makamure B, Chirehwa M, Sagonda T, Zinyowera S, Mason P ...
Open Forum Infectious Diseases 1 (1), ofu038, 2014
Model-based evaluation of higher doses of rifampin using a semimechanistic model incorporating autoinduction and saturation of hepatic extraction
MT Chirehwa, R Rustomjee, T Mthiyane, P Onyebujoh, P Smith, ...
Antimicrobial agents and chemotherapy 60 (1), 487-494, 2015
Use of the ‘accountability for reasonableness’ approach to improve fairness in accessing dialysis in a middle-income country
MR Moosa, JD Maree, MT Chirehwa, SR Benatar
PLoS One 11 (10), e0164201, 2016
Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB
A Naidoo, M Chirehwa, H McIlleron, K Naidoo, S Essack, N Yende-Zuma, ...
Journal of Antimicrobial Chemotherapy 72 (5), 1441-1449, 2017
Pharmacokinetics of pyrazinamide and optimal dosing regimens for drug-sensitive and-resistant tuberculosis
MT Chirehwa, H McIlleron, R Rustomjee, T Mthiyane, P Onyebujoh, ...
Antimicrobial agents and chemotherapy 61 (8), e00490-17, 2017
CYP2B6 genotype and weight gain differences between dolutegravir and efavirenz
R Griesel, G Maartens, M Chirehwa, S Sokhela, G Akpomiemie, ...
Clin Infect Dis 70, 670-678, 2020
Current research toward optimizing dosing of first-line antituberculosis treatment
H McIlleron, MT Chirehwa
Expert review of anti-infective therapy 17 (1), 27-38, 2019
HIV-1 coinfection does not reduce exposure to rifampin, isoniazid, and pyrazinamide in South African tuberculosis outpatients
N Rockwood, G Meintjes, M Chirehwa, L Wiesner, H McIlleron, ...
Antimicrobial agents and chemotherapy 60 (10), 6050-6059, 2016
Renal abnormalities among HIV-infected, antiretroviral naive children, Harare, Zimbabwe: a cross-sectional study
V Dondo, HA Mujuru, KJ Nathoo, M Chirehwa, Z Mufandaedza
BMC pediatrics 13 (1), 1-9, 2013
Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis
A Naidoo, M Chirehwa, V Ramsuran, H McIlleron, K Naidoo, ...
Pharmacogenomics 20 (04), 225-240, 2019
Effect of efavirenz-based antiretroviral therapy and high-dose rifampicin on the pharmacokinetics of isoniazid and acetyl-isoniazid
MT Chirehwa, H McIlleron, L Wiesner, D Affolabi, O Bah-Sow, C Merle, ...
Journal of Antimicrobial Chemotherapy 74 (1), 139-148, 2019
Quality assurance of rifampicin-containing fixed-drug combinations in South Africa: dosing implications
MT Chirehwa, L Wiesner, B Wright, W Smythe, N Kramer, H McIlleron
The International Journal of Tuberculosis and Lung Disease 22 (5), 537-543, 2018
Evaluation of the effectiveness of dose individualization to achieve therapeutic vancomycin concentrations
AA Abulfathi, M Chirehwa, B Rosenkranz, EH Decloedt
The Journal of Clinical Pharmacology 58 (9), 1134-1139, 2018
Propagation of measurement errors in glomerular filtration rate determination: a comparison of slope–intercept, single-sample and slope-only methods
JL Holness, JS Fleming, MT Chirehwa, JM Warwick
Nuclear medicine communications 40 (4), 333-342, 2019
Assessment of quality of obstetric care in Zimbabwe using the standard primipara
BT Guzha, TL Magwali, B Mateveke, M Chirehwa, G Nyandoro, ...
BMC pregnancy and childbirth 18 (1), 1-6, 2018
Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis
A Naidoo, V Ramsuran, M Chirehwa, P Denti, H McIlleron, K Naidoo, ...
Pharmacogenomics 19 (1), 17-29, 2018
Elective reconstruction of the ascending aorta for aneurysmal disease restores normal life expectancy. An analysis of risk factors for early and late mortality
D Van Duffel, R Van Gemert, P Starinieri, JL Pauwels, A Natukunda, ...
Acta cardiologica 68 (4), 349-353, 2013
Low antituberculosis drug concentrations in HIV-tuberculosis-coinfected adults with low body weight: Is it time to update dosing guidelines?
C Sekaggya-Wiltshire, M Chirehwa, J Musaazi, A von Braun, A Buzibye, ...
Antimicrobial agents and chemotherapy 63 (6), e02174-18, 2019
Population pharmacokinetics of cycloserine and pharmacokinetic/pharmacodynamic target attainment in multidrug-resistant tuberculosis patients dosed with terizidone
MT Chirehwa, R Court, M de Kock, L Wiesner, N de Vries, J Harding, ...
Antimicrobial agents and chemotherapy 64 (11), e01381-20, 2020
The system can't perform the operation now. Try again later.
Articles 1–20